AmCAD-UO
Overview
AmCAD-UO is an innovative, AI-powered ultrasound solution developed by AmCad BioMed Corporation, designed to assist physicians in the evaluation and monitoring of Obstructive Sleep Apnea (OSA) syndrome. The system comprises a precise positioning system and a computer-assisted detection (CAD) software device. It works by acquiring multiple-angle sonographic images of the upper airway using an FDA-cleared ultrasound system. The software then automatically detects the airspace of the pharyngeal airway and computes dynamic changes to assess the risk of OSA. This non-invasive evaluation process is performed on awake patients and delivers results in approximately 10 minutes, offering an objective, accurate, cost-effective, and safe approach to OSA diagnosis.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered ultrasound analysis for Obstructive Sleep Apnea (OSA)
- Non-invasive upper airway scanning
- Computer-assisted detection (CAD) software
- Automatic detection of pharyngeal airway airspace
- Dynamic change computation of airspace for OSA risk evaluation
- 10-minute assessment on awake patients
- Objective, accurate, cost-effective, and safe evaluation process
- Laser-guided positioning for precise scanning
- 3D anatomic airway assessment
- Standardizes ultrasound transducer scanning to reduce intra-observer variations
Use Cases
- Evaluating the risk of Obstructive Sleep Apnea (OSA) syndrome
- Assessing moderate/severe OSA patients
- Identifying the root cause of sleep apnea
- Evaluating patients for tongue reduction surgery (ENT)
- Assessing the effectiveness of oral appliances in dentistry
- Precision treatment and follow-up in clinical settings for OSA
What Physicians Need to Know
AmCAD-UO provides a rapid, non-invasive, and quantitative assessment of the upper airway for Obstructive Sleep Apnea (OSA) in awake patients, taking approximately 10 minutes. This can significantly expedite initial evaluations and aid in patient selection for various OSA treatments, including advanced therapies like hypoglossal nerve stimulation, by offering objective anatomical and functional insights. Physicians should integrate the AI-powered assessment as a supportive tool for evaluation and monitoring, not as a standalone diagnostic. The system's ability to standardize ultrasound transducer scanning also helps reduce operator-dependent variations, leading to more consistent assessments.
AmCAD-UO is designed to be PACS compatible, facilitating integration into existing radiology workflows. Its ability to analyze DICOM files from various ultrasound systems ensures broad compatibility. For optimal utility, consider integrating the AI-generated reports and quantitative data directly into the PACS and potentially the Electronic Health Record (EHR) system to ensure a seamless flow of information and comprehensive patient records. This integration can help radiologists and referring clinicians access critical OSA assessment data efficiently within their established viewing and reporting environments.
Details
| Category | Radiology & Imaging AI |
| Pricing | Contact for pricing — N/A |
| Deployment | PC-based software application, integrated with FDA-cleared ultrasound systems |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated AmCAD-UO received FDA 510(k) clearance (K180867) on December 28, 2018. It is classified under 21 CFR 892.2050, Picture Archiving And Communications System, product code LLZ. The software is intended for reviewing pharyngeal/upper airway ultrasonic images acquired from FDA-cleared ultrasound systems to support visualization and quantification of airway sonographic characteristics for physician evaluation and monitoring. |
| Integrations | |
| EHR | Not specified |
| Specialties | Otolaryngology (ENT), Radiology, Sleep Medicine |
What the Web Says
AmCAD-UO is an AI-powered ultrasound system designed to assist physicians in evaluating the risk of Obstructive Sleep Apnea (OSA) by scanning the patient's neck and analyzing the upper airway. It provides a 3D reconstruction of the airway and an AI-powered assessment report, predicting the risk of severe sleep apnea. The process is objective, accurate, cost-effective, and safe, taking about 10 minutes for awake patients. The system has also shown promise in predicting suitable patients for hypoglossal nerve stimulation (HNS) therapy with nearly 80% accuracy.
Overall: PositiveStrengths
- AI-powered assessment for objective and accurate results.
- Non-invasive and radiation-free imaging.
- Quick evaluation process (around 10 minutes) for awake patients.
- Provides a 3D reconstruction of the upper airway for a comprehensive view.
- Potential to evaluate CPAP alternatives and assess effectiveness of therapies.
- Useful for ENT practices, surgeons, and dentists to examine patient anatomy.
Limitations
- Sleep medicine practitioners may lack training in ultrasonography, raising questions about its immediate clinical role in this subspecialty.
- Must not be used alone for primary diagnostic interpretation.
- Limited information available from independent tech reviewers, Reddit, G2, or Capterra specifically for AmCAD-UO. (No direct mentions found in search results)
- Some general employee reviews for AmCad (the parent company) mention unstable work environment, low pay, and poor work-life balance.
Based on reviews from: Sleep Review, Taiwan Excellence Award, Commercial Times, Indeed.com, Stanford Medicine
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate AmCAD-UO
Videos
Product demos, reviews, and walkthroughs for AmCAD-UO.
AmCAD-UO Introduction (150 sec)
AmCad BioMed
